Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: WellPoint, Inc. (NYSE:WLP), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Rockwell Medical Inc (NASDAQ:RMTI), Celsion Corporation (NASDAQ:CLSN)
WellPoint, Inc. (NYSE:WLP) managed to keep its gain at 0.84% on above-normal volume of 2.20M shares. The stock settled at $87.21 after floating in a range of $86.07 to $87.86. Its latest price has reached market capitalization of $26.07 billion. Its 52-week range has been $53.69 to $90. WellPoint, Inc. (WellPoint) is a health benefit company in terms of medical membership in the United States, serving 34.3 million medical members through its affiliated health plans and a total of 65.3 million individuals through all subsidiaries as of December 31, 2011.
For How Long WLP will fight for Profitability? Read This Trend Analysis report
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) traded up on a volume of 2.14 million, higher than its standard daily volume. Shares have gained 11.96% to $4.68. Over the last twelve months, the stock has lost-14.13% and faced a worst price of $1.49. ZIOPHARM Oncology, Inc. (ZIOPHARM) is a biopharmaceutical company that focuses on the discovery and development of new cancer therapies. ZIOPHARM is applying its technologies in cancer research to develop therapeutics for patients.
For How Long ZIOP’s Gloss will Attract Investors? Find out via this report
Rockwell Medical Inc (NASDAQ:RMTI) settled 0.40% higher at $12.46 on below -normal volume of 2.02M shares during the last trading day. The stock has its 12-month high at $13 and 52-week low price was $3.16. It traded in a range of $12.40 to $12.80 during the last trading day. Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells.
Why Should Investors Buy RMTI After the Recent Fall? Just Go Here and Find Out
In the last trading session, Celsion Corporation (NASDAQ:CLSN) was up on high volume, trading at a volume of 1.98M versus its average daily volume of 1.64 million shares. At $1.27, the stock has attained market capitalization of 77.67 million.Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.
Will CLSN Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)